AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ANTERIS TECHNOLOGIES LTD

8.300

-0.250-2.92%

Volume:37.62K

Turnover:313.07K

Market Cap:299.32M

PE:-1.41

High:8.750

Open:8.550

Low:8.000

Close:8.550

Loading ...

Overview Company News Filings

ASX Runners of the Week: Redstone Resources, Anteris & Jindalee Lithium

The Sydney Morning Herald

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

Anteris Technologies Says Over 100 Patients Treated with Aortic Stenosis Medical Device; Shares Down 6%

MT Newswires Live

Anteris Technologies Reports Positive One-Year Results for Patients Treated with Transcatheter Heart Valve System

MT Newswires Live

Top Premarket Gainers

MT Newswires Live

Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays

Anteris Technologies Receives Australian Taxation Office Class Rulings

MT Newswires Live

Anteris Technologies' IPO Underwriters' Representatives Partially Exercise Over-Allotment Option; Shares Up 3%

MT Newswires Live

BUZZ-Anteris Technologies up as brokerages initiate coverage post-research quiet period

Anteris Technologies Ltd-Update - Proposed Issue of Securities - Avr

THOMSON REUTERS

Anteris Technologies Completes $89 Million US IPO; to list CDIs on ASX; Shares Fall 15%

MT Newswires Live

BRIEF-Anteris Technologies Says Aggregate Gross Proceeds From Offering Was $88.8 Mln

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

THOMSON REUTERS

Anteris Technologies - Aggregate Gross Proceeds From Offering US$88.8 Mln

THOMSON REUTERS

Anteris Technologies Global Joins ASX Official List Monday

MT Newswires Live

BUZZ-Anteris Technologies slides in Nasdaq debut after $89 mln US IPO

Anteris Technologies Global Prices US IPO

MT Newswires Live

Anteris Technologies - Pricing of Its Initial Public Offering of US$6.00 per Share

THOMSON REUTERS

BRIEF-Anteris Technologies Prices 14.8 Mln Shares At $6.00 Per Share for U.S. IPO

Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVR.AU\",,,,,undefined,":{"symbol":"AVR.AU","market":"AU","secType":"STK","nameCN":"ANTERIS TECHNOLOGIES LTD","latestPrice":8.3,"timestamp":1746079920000,"preClose":8.55,"halted":0,"volume":37616,"delay":0,"nameEN":"ANTERIS TECHNOLOGIES LTD","floatShares":27479955,"shares":36062370,"eps":-5.8971628152362285,"marketStatus":"Not Yet Opened","change":-0.25,"latestTime":"05-01 16:12:00 AEST","open":8.55,"high":8.75,"low":8,"amount":313067,"amplitude":0.087719,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.8971628152362285,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":8.55,"openAndCloseTimeList":[[1746057600000,1746079200000]],"volumeRatio":0.9849905219119441,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVR.AU\",,,,,undefined,":{"symbol":"AVR.AU","floatShares":27479955,"roa":"-88.08%","roe":"-186.24%","lyrEps":-5.897163,"volumeRatio":0.9849905219119441,"shares":36062370,"dividePrice":0,"high":8.75,"amplitude":0.087719,"preClose":8.55,"low":8,"week52Low":4.26,"pbRate":"3.05","psRate":"70.73","week52High":21.7,"institutionHeld":0,"latestPrice":8.3,"eps":-5.8971628152362285,"divideRate":0,"volume":37616,"delay":0,"ttmEps":-5.8971628152362285,"open":8.55,"prevYearClose":8.27,"prevWeekClose":7.5,"prevMonthClose":8.55,"prevQuarterClose":6.5,"fiveDayClose":5.62,"twentyDayClose":6.5,"sixtyDayClose":9.99},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVR.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529620992","title":"ASX Runners of the Week: Redstone Resources, Anteris & Jindalee Lithium","url":"https://stock-news.laohu8.com/highlight/detail?id=2529620992","media":"The Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529620992?lang=en_us&edition=fundamental","pubTime":"2025-04-24 16:04","pubTimestamp":1745481840,"startTime":"0","endTime":"0","summary":"On a short week, the markets saw a nice post-Easter bump with the ASX finishing up 2.5 per cent across three days, primarily thanks to another volatile Trump tariff backflip - this time with China.After weeks of escalating China-United States trade war tensions, US President Donald Trump announced plans to cut the unprecedented 140 per cent tariffs placed on China, perhaps understanding his game of chicken with the largest export nation in the world might not turn out to be as rosy as he had hoped.This week’s Bulls N’ Bears ASX Runner of the Week is…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/asx-runners-of-the-week-redstone-resources-anteris-and-jindalee-lithium-20250424-p5lu34.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["IE00B5TLWC47.USD","BK4104","BK7511","BK4585","IE00BFXG0V08.USD","FAST","BK7095","BHP.AU","BK4567","JLL.AU","BK4588","BK7126","AVR.AU","IE00BYQQ9H92.USD","RDS.AU","PLS.AU","BK7507","BK7007","BK7504"],"gpt_icon":0},{"id":"2523910613","title":"Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910613","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910613?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:15","pubTimestamp":1743419700,"startTime":"0","endTime":"0","summary":"MINNEAPOLISand BRISBANE, Australia, March 31, 2025  -- Anteris Technologies Global Corp.   a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices, announces a significant milestone in our mission to restore heart valve patients to healthy function. Our first in class, biomimetic DurAVR Transcatheter Heart Valve  has now been used to treat over 100 patients worldwide, marking a major achievement in our goal to revolutionize cardiac care in patients affected by severe aortic stenosis.Over 100 patients successfully treated with the DurAVR THV, including de novo  aortic stenosis cases, valve-in-valve  patients and complex anatomies such as bicuspid aortic valve patients*. Dr. Michael Reardon, Allison Family Distinguished Chair of Cardiovascular Research and Professor of Cardiothoracic Surgery at the Houston Methodist Hospital and Study Chair of the DurAVR THV Pivotal Trial said, “We are building on a strong foundation of clini","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/anteris-technologies-reaches-clinical-milestone-111500161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","AVR","AVR.AU"],"gpt_icon":0},{"id":"2523314249","title":"Anteris Technologies Says Over 100 Patients Treated with Aortic Stenosis Medical Device; Shares Down 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2523314249","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523314249?lang=en_us&edition=fundamental","pubTime":"2025-03-31 09:22","pubTimestamp":1743384148,"startTime":"0","endTime":"0","summary":"Anteris Technologies  said its biomimetic DurAVR transcatheter heart valve  has been used to treat over 100 patients worldwide, according to a Monday filing with the Australian bourse.Among the patients, 65 completed the primary endpoint measures of safety and efficacy, the filing said.The company plans to begin the DurAVR THV pivotal trial in the third quarter of the year, awaiting US Food and Drug Administration approval, per the filing.Shares were down 6% in morning trade on Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","BK7007","AVR.AU"],"gpt_icon":0},{"id":"2521411656","title":"Anteris Technologies Reports Positive One-Year Results for Patients Treated with Transcatheter Heart Valve System","url":"https://stock-news.laohu8.com/highlight/detail?id=2521411656","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521411656?lang=en_us&edition=fundamental","pubTime":"2025-03-21 08:53","pubTimestamp":1742518392,"startTime":"0","endTime":"0","summary":"Anteris Technologies  said that one-year results for patients treated with its proprietary, balloon expandable, DurAVR Transcatheter Heart Valve system showed sustained \"excellent\" effective orifice area, low mean gradients, and zero prosthesis-patient mismatch small annuli patients, according to a Friday Australian bourse filing.The DurAVR THV demonstrated a favorable hemodynamic profile sustained to one-year. No valve or cardiovascular-related mortality was reported.Current commercial devices demonstrated prosthesis-patient mismatch rates of between 11.2% to 35.3%, a predictor of valve failure and disease progression.The one-year data builds on the existing clinical evidence and will be included in the planned Investigational Device Exemption submission to the US Food and Drug Administration to seek approval to conduct a DurAVR THV randomized, global pivotal study.A total of 65 patients completed the primary endpoint measure at 30 days.Its shares slid 2% in early trading on Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVR.AU","BK7007","BK7126"],"gpt_icon":0},{"id":"2520845848","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2520845848","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520845848?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:42","pubTimestamp":1742470946,"startTime":"0","endTime":"0","summary":"OptiNose (OPTN) shares soared 58% pre-bell Thursday after the company said overnight it agreed to a $330 million takeover by Paratek Pharmaceuticals.ProAssurance (PRA) shares surged 49% after the comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4107","AVR","BK7007","OPTN","AVR.AU","BK7126","BK4082","PRA"],"gpt_icon":0},{"id":"2514288329","title":"Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2514288329","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514288329?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS and BRISBANE, Australia, Feb. 28, 2025  -- Anteris Technologies Global Corp.   a structural heart company developing DurAVRTHV, a first-in-class, biomimetic, balloon expandable heart valve, is pleased to advise that Chief Executive Officer, Wayne Paterson will be presenting at both the 45th Annual TD Cowen Healthcare Conference, and the Barclays 27th Annual Global Healthcare Conference.The details of each conference and how to access them are as follows:. Fireside chat with analyst, Joshua Jennings, and 1x1 meetings. Anteris’ lead product, the DurAVR Transcatheter Heart Valve , was designed in partnership with the world’s leading interventional cardiologists and cardiac surgeons to treat aortic stenosis – a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood fl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/anteris-present-healthcare-investor-conferences-130000956.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4127","BK4207","BK4585","TD","BK4082","AVR.AU","BK7126","COWN","AVR","BK4566","BK4137","HCSG","BK7007"],"gpt_icon":0},{"id":"2511469502","title":"Anteris Technologies Receives Australian Taxation Office Class Rulings","url":"https://stock-news.laohu8.com/highlight/detail?id=2511469502","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511469502?lang=en_us&edition=fundamental","pubTime":"2025-02-14 07:41","pubTimestamp":1739490110,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global  said that the Australian Taxation Office  has issued three class rulings related to the company, according to a Thursday filing with the Australian bourse.The rulings cover shareholders, employee, director options, and investor options and confirm the availability of rollover relief for eligible parties under relevant Australian capital gains tax laws, following the implementation of Anteris' schemes of arrangement, the filing said.Price : $12.85, Change: $-0.19, Percent Change: -1.46%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ATO","BK7007","AVR.AU","BK4585","XJO.AU","AUD","LU0994945656.USD","XAO.AU","LU1043141123.HKD","LU2238339852.HKD","BK7126","XKO.AU","BK4125","LU0426417589.USD","BK4197","BK4588","LU0345774631.USD","LU0426412945.USD"],"gpt_icon":0},{"id":"2503465835","title":"Anteris Technologies' IPO Underwriters' Representatives Partially Exercise Over-Allotment Option; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503465835","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503465835?lang=en_us&edition=fundamental","pubTime":"2025-01-15 09:51","pubTimestamp":1736905886,"startTime":"0","endTime":"0","summary":"Anteris Technologies  said the representatives of the underwriters of its US initial public offering partially exercised the over-allotment option for 78,481 common shares at $6 apiece, less underwriting discounts and commissions of $0.42 per share, according to a Wednesday filing with the Australian bourse.The representatives are TD Cowen, Barclays, and Cantor. The portion of the over-allotment option that was not exercised lapsed on Jan. 11. Settlement occurred on Jan. 14.Separately, TD Cowen ceased its market stabilization activities on Jan. 12. During the stabilization period, TD Cowen purchased over 2.1 million common shares for prices ranging from $5.14 to $6 on the Nasdaq market.Anteris Technologies' shares were up more than 3% in recent Wednesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7126","AVR.AU"],"gpt_icon":0},{"id":"2501839987","title":"BUZZ-Anteris Technologies up as brokerages initiate coverage post-research quiet period","url":"https://stock-news.laohu8.com/highlight/detail?id=2501839987","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501839987?lang=en_us&edition=fundamental","pubTime":"2025-01-07 23:10","pubTimestamp":1736262624,"startTime":"0","endTime":"0","summary":"** Shares of heart valve maker Anteris Technologies    rise as much as 6.8%; last up 4.2% at $5.84 in early trading   ** Wall Street brokerages start coverage of AVR as IPO research quiet period comes to an end   ** Barclays initiates coverage with \"overweight\" rating and $22 PT, a 292.2% upside to stock's last close   ** Brokerage says AVR's transcatheter aortic valve replacement  platform is positioned to capture 4%-5% of the U.S. TAVR market   ** Adds that the timing for AVR's entry into TAVR could not look better   ** TD Cowen initiates coverage with \"buy\" rating and $15 PT, a 167.4% upside to stock's last close   ** Brokerage says AVR's TAVR platform has disruptive potential that fills unmet needs in the industry   ** Adds that AVR should capture meaningful share in the ~$10 bln TAVR market   ** TD Cowen, Barclays and Cantor were the joint book-running managers for AVR's IPO   ** As of last close, AVR shares down 6.5% since Nasdaq debut on Dec. 13 ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR.AU","BK7126","BK7007","BK4082","AVR"],"gpt_icon":0},{"id":"2492453529","title":"Anteris Technologies Ltd-Update - Proposed Issue of Securities - Avr","url":"https://stock-news.laohu8.com/highlight/detail?id=2492453529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492453529?lang=en_us&edition=fundamental","pubTime":"2024-12-20 10:00","pubTimestamp":1734660025,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUE2LMYMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","AVR.AU","BK7126"],"gpt_icon":0},{"id":"2492609275","title":"Anteris Technologies Completes $89 Million US IPO; to list CDIs on ASX; Shares Fall 15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492609275","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492609275?lang=en_us&edition=fundamental","pubTime":"2024-12-17 12:00","pubTimestamp":1734408014,"startTime":"0","endTime":"0","summary":"Anteris Technologies  completed its initial public offering in the US, issuing 14.8 million shares at $6 each to raise gross proceeds of $88.8 million, according to a Tuesday filing with the Australian bourse.The company's stock started trading on the Nasdaq Global Market under the ticker \"AVR\" on Dec. 13, the filing said.The company will also list its Chess Depositary Interests on the Australian stock exchange under the ticker \"AVR,\" the filing added.The company plans to use the proceeds from the IPO to fund the development of its DurAVR transcatheter heart valve and a global clinical study for the valve to treat aortic stenosis, with remaining funds for working capital and debt repayment.Shares of the company fell nearly 15% in recent Tuesday trade.Price : $9.00, Change: $-1.54, Percent Change: -14.61%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","LU0994945656.USD","XJO.AU","BK7007","LU2238339852.HKD","BK7126","LU0345774631.USD","LU1043141123.HKD","LU0426417589.USD","XKO.AU","LU0426412945.USD","BK4125","AVR.AU","AUD"],"gpt_icon":0},{"id":"2492367676","title":"BRIEF-Anteris Technologies Says Aggregate Gross Proceeds From Offering Was $88.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2492367676","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492367676?lang=en_us&edition=fundamental","pubTime":"2024-12-17 09:09","pubTimestamp":1734397746,"startTime":"0","endTime":"0","summary":"BRIEF-Anteris Technologies Says Aggregate Gross Proceeds From Offering Was $88.8 MlnDec 17 (Reuters) - Anteris Technologies Ltd AVR.AX:AGGREGATE GROSS PROCEEDS FROM OFFERING US$88.8 MILLIONFurther company coverage: AVR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NH0R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR.AU","BK7007","BK7126"],"gpt_icon":0},{"id":"2492754266","title":"Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2492754266","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492754266?lang=en_us&edition=fundamental","pubTime":"2024-12-17 08:49","pubTimestamp":1734396542,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUA31GBJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK7007","BK7126","AVR","AVR.AU"],"gpt_icon":0},{"id":"2492621239","title":"Anteris Technologies -  Aggregate Gross Proceeds From Offering US$88.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2492621239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492621239?lang=en_us&edition=fundamental","pubTime":"2024-12-17 06:51","pubTimestamp":1734389467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH0R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7126","AVR.AU"],"gpt_icon":0},{"id":"2491639628","title":"Anteris Technologies Global Joins ASX Official List Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2491639628","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491639628?lang=en_us&edition=fundamental","pubTime":"2024-12-16 13:19","pubTimestamp":1734326371,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global  was admitted to the official list of the Australian Securities Exchange Monday, according to a same-day filing with the Australian bourse.The move was made following parent biotechnology firm Anteris Group's decision to re-domicile in the US from Australia.Anteris Technologies Global expects its CHESS depositary interest will start quotation on Dec. 17, the filing said.It expects to raise $88.8 million via its initial public offer on the Nasdaq which is expected to close on Monday, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","AVR.AU","XJO.AU","XAO.AU","BK7007","XKO.AU"],"gpt_icon":0},{"id":"2491926302","title":"BUZZ-Anteris Technologies slides in Nasdaq debut after $89 mln US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2491926302","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491926302?lang=en_us&edition=fundamental","pubTime":"2024-12-14 03:31","pubTimestamp":1734118299,"startTime":"0","endTime":"0","summary":"** Shares of heart company Anteris Technologies    slide 12.3% to $5.26 in their Nasdaq debut    ** Stock opened for trading at $6, valuing the company at $215.6 mln   ** AVR sold 14.8 mln shares in its New York IPO at $6/shr to raise $88.8 mln   ** Offering priced at a 11.5% discount to the Dec. 5 closing price of its shares on the Australian Securities Exchange   ** TD Cowen, Barclays and Cantor were the joint book-running managers for the offering   ** AVR will use the proceeds to fund the development of its transcatheter heart valve, among other purposes ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","USAW.SI","AVR","NDAQ","TQQQ","MNQmain","NQmain","BK4585","BK4112","USJW.SI","QID",".IXIC","LU2210149790.SGD","QLD","BK4588","BK7126","AVR.AU","TSYW.SI","PSQ","NVIW.SI","BK7007","LU2095319765.USD","LU2210150020.SGD","SQQQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2491327025","title":"Anteris Technologies Global Prices US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2491327025","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491327025?lang=en_us&edition=fundamental","pubTime":"2024-12-13 21:29","pubTimestamp":1734096589,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global  said late Thursday that it has priced a US initial public offering of 14.8 million shares at $6.00 each.The shares are expected to begin trading Friday on Nasdaq under the ticker \"AVR.\"  The company said it expects the offering to close Monday.The Australian medical device maker also said it has given underwriters a 30-day option to purchase up to 2.2 million additional shares.The company said the net proceeds from the offering, along with existing cash, will be used for development of its DurAVR transcatheter heart valve, as well as to prepare for and enroll in a study of the device for treating severe aortic stenosis and for other general corporate purposes.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","AVR","AVR.AU","BK7126"],"gpt_icon":0},{"id":"2491349647","title":"Anteris Technologies -  Pricing of Its Initial Public Offering of US$6.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2491349647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491349647?lang=en_us&edition=fundamental","pubTime":"2024-12-13 17:11","pubTimestamp":1734081089,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nFWN3NE0EC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","BK7007","AVR.AU"],"gpt_icon":0},{"id":"2491394746","title":"BRIEF-Anteris Technologies Prices 14.8 Mln Shares At $6.00 Per Share for U.S. IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2491394746","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491394746?lang=en_us&edition=fundamental","pubTime":"2024-12-13 11:36","pubTimestamp":1734060981,"startTime":"0","endTime":"0","summary":"Dec 12 (Reuters) - Anteris Technologies Ltd   :   * ANTERIS TECHNOLOGIES GLOBAL CORP. ANNOUNCES PRICING OF U.S. INITIAL PUBLIC OFFERING   * ANTERIS TECHNOLOGIES LTD - PRICING OF 14.8 MILLION SHARES AT $6.00 PER SHARESource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","AVR.AU","BK7007"],"gpt_icon":0},{"id":"2491394235","title":"Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2491394235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491394235?lang=en_us&edition=fundamental","pubTime":"2024-12-13 11:34","pubTimestamp":1734060844,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nFWN3ND1FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","BK7007","AVR.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-12-11","symbol":"AVR.AU","reason":null,"defaultRemindTime":1733871600000,"announcedDate":"2024-09-05","type":"delisting","dateTimestamp":1733835600000},{"market":"AU","date":"2024-10-15","symbol":"AVR.AU","reason":null,"defaultRemindTime":1728946800000,"announcedDate":"2024-09-05","type":"delisting","dateTimestamp":1728910800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVR.AU\",market:\"AU\",,,undefined,":[]}}